Stephen K. Doberstein
2012
In 2012, Stephen K. Doberstein earned a total compensation of $1.1M as Senior Vice President and Chief Scientific Officer at Nektar Therapeutics, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $260,000 |
|---|---|
| Option Awards | $377,540 |
| Salary | $433,605 |
| Other | $9,613 |
| Total | $1,080,758 |
Doberstein received $433.6K in salary, accounting for 40% of the total pay in 2012.
Doberstein also received $260K in non-equity incentive plan, $377.5K in option awards and $9.6K in other compensation.
Rankings
In 2012, Stephen K. Doberstein's compensation ranked 5,817th out of 11,487 executives tracked by ExecPay. In other words, Doberstein earned more than 49.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,817 out of 11,487 | 49th |
Division Manufacturing | 2,065 out of 4,253 | 51st |
Major group Chemicals And Allied Products | 513 out of 1,198 | 57th |
Industry group Drugs | 348 out of 920 | 62nd |
Industry Pharmaceutical Preparations | 274 out of 700 | 61st |
Source: SEC filing on April 30, 2015.
Doberstein's colleagues
We found four more compensation records of executives who worked with Stephen K. Doberstein at Nektar Therapeutics in 2012.